Navamedic ASA: Recommendation of the nomination committee for the Annual General Meeting on 23 April 2026

Oslo, 15 April 2026: Reference is made to the stock exchange announcement by Navamedic ASA published on 31 March 2026, regarding the company's annual general meeting being held on 23 April 2026. The nomination committee's recommendation was not available at the time the notice was distributed but has now been submitted to the annual general meeting.

The nomination committee has nominated the following persons to members of the company's board of directors: - Candidate 1: Morten Jurs nominated as chairperson - Candidate 2: Rune Wahl nominated as board member - Candidate 3: Hilde Furberg nominated as board member - Candidate 4: Camilla Harder Hartvig nominated as board member - Candidate 5: Mads Helmich Pedersen nominated as board member - Candidate 6: Otto Moltke-Hansen nominated as board observer - Candidate 7: position is intentionally left vacant

In addition, the nomination committee has nominated the following persons as members of the company's nomination committee: - Candidate 1: Bård Brath Ingerø nominated as leader - Candidate 2: Katarina Hammar nominated as member - Candidate 3: Karianne Melleby nominated as member

The nomination committee's recommendation, including inter alia, information on proposed remuneration to members of the board of directors, the various board committees and the nomination committee is attached hereto and will be made available on the company's website https://navamedic.com/investors/general-meeting/.

At the annual general meeting, the shareholders will vote on the candidates on an individual basis in accordance with the Norwegian Code of Practice for Corporate Governance (NUES). Votes and proxies already submitted will remain valid, and there is no need to vote again or submit a new proxy as a result of this announcement.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.